Topical administration of EGF suppresses immune response and protects skin barrier in DNCB-induced atopic dermatitis in NC/Nga mice
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Young-Je | - |
dc.contributor.author | Choi, Mi Ji | - |
dc.contributor.author | Bak, Dong-Ho | - |
dc.contributor.author | Lee, Byung Chul | - |
dc.contributor.author | Ko, Eun Jung | - |
dc.contributor.author | Ahn, Ga Ram | - |
dc.contributor.author | Ahn, Seung Won | - |
dc.contributor.author | Kim, Moo Joong | - |
dc.contributor.author | Na, Jungtae | - |
dc.contributor.author | Kim, Beom Joon | - |
dc.date.available | 2019-03-07T04:35:11Z | - |
dc.date.issued | 2018-08 | - |
dc.identifier.issn | 2045-2322 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/1885 | - |
dc.description.abstract | Atopic dermatitis (AD) is a common inflammatory skin disease characterized by a complex, heterogeneous pathogenesis including skin barrier dysfunction, immunology, and pruritus. Although epidermal growth factor (EGF) is essential for epithelial homeostasis and wound healing, the effect of EGF on AD remains to be explored. To develop a new therapy for AD, the anti-AD potential of EGF was investigated by inducing AD-like skin lesions in NC/Nga mice using 2,4-dinitrochlorobenzene (DNCB). EGF was administrated to NC/Nga mice to evaluate its therapeutic effect on DNCB-induced AD. EGF treatment improved dermatitis score, ear thickness, epidermal hyperplasia, serum total immunoglobulin E level, and transepidermal water loss in NC/Nga mice with DNCB-induced AD. In addition, levels of skin barrier-related proteins such as filaggrin, involucrin, loricrin, occludin, and zonula occludens-1 (ZO-1) were increased by EGF treatment. These beneficial effects of EGF on AD may be mediated by EGF regulation of Th1/Th2-mediated cytokines, mast cell hyperplasia, and protease activated receptor-2 (PAR-2) and thymic stromal lymphopoietin (TSLP), which are triggers of AD. Taken together, our findings suggest that EGF may potentially protect against AD lesional skin via regulation of skin barrier function and immune response. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | NATURE PUBLISHING GROUP | - |
dc.title | Topical administration of EGF suppresses immune response and protects skin barrier in DNCB-induced atopic dermatitis in NC/Nga mice | - |
dc.type | Article | - |
dc.identifier.doi | 10.1038/s41598-018-30404-x | - |
dc.identifier.bibliographicCitation | SCIENTIFIC REPORTS, v.8, no.1 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000441159800001 | - |
dc.identifier.scopusid | 2-s2.0-85051465759 | - |
dc.citation.number | 1 | - |
dc.citation.title | SCIENTIFIC REPORTS | - |
dc.citation.volume | 8 | - |
dc.type.docType | Article | - |
dc.publisher.location | 영국 | - |
dc.subject.keywordPlus | EPIDERMAL-GROWTH-FACTOR | - |
dc.subject.keywordPlus | THYMIC STROMAL LYMPHOPOIETIN | - |
dc.subject.keywordPlus | FACTOR RECEPTOR INHIBITORS | - |
dc.subject.keywordPlus | TRANSEPIDERMAL WATER-LOSS | - |
dc.subject.keywordPlus | STRATUM-CORNEUM LIPIDS | - |
dc.subject.keywordPlus | EPITHELIAL-CELLS | - |
dc.subject.keywordPlus | NULL MICE | - |
dc.subject.keywordPlus | TNF-ALPHA | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | FILAGGRIN | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalWebOfScienceCategory | Multidisciplinary Sciences | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.